Clinical Endocrinology · 1986 · 19 citations · 11 references
MedicineEndocrinologyPharmacologyNeuroendocrinologyNeuropharmacologyPharmacodynamicsCholinergic PharmacologyHormone ReleaseHormone SecretionHypothalamic-pituitary RegulationPituitary Gland FunctionPituitary HormonesAtropine UseHypothalamic Hormone SecretionHypothalamic HormonesHypothalamic-releasing HormonesMuscarinic Receptor PharmacologyMuscarinic ReceptorsPituitary Peptide HormonesTreatment With Atropine
The role of acetylcholine in the regulation of the hypothalamo-pituitary system in man was assessed using atropine, which selectively blocks cholinergic muscarinic receptors. Paired tests were performed in 10 normal men using either GHRH (1 microgram/kg i.v.), or TRH (300 micrograms i.v.) plus LHRH (100 micrograms i.v.) plus corticotrophin releasing hormone (CRH) (1 microgram/kg i.v.) with or without atropine given 30 min previously (1 mg i.m.). The GHRH-induced GH secretory peak (17.8 +/- 3.0 ng/ml) was completely blocked by atropine administration (2.8 +/- 0.6 ng/ml) (P less than 0.05). Atropine did not, however, modify TRH-induced TSH and PRL secretion, nor FSH and LH release induced by the LHRH pulse. ACTH/cortisol secretion elicited by CRH was also unaffected by atropine. These results suggest that atropine blockade of GHRH-induced GH secretion is highly specific, and constitutes an indication of the importance of cholinergic control of GH function. Furthermore, atropine's lack of action on the other pituitary hormones rules out the possibility that it acts non-specifically, i.e. via blood flow changes or toxic effects.
11
M. T. Jones, Edward W. Hillhouse, Janet Burden · Journal of Endocrinology · 1976 · 257 citations
Methscopolamine Inhibition of Sleep-Related Growth Hormone Secretion
Wallace B. Mendelson, N. Sitaram, Richard Jed Wyatt et al. · Journal of Clinical Investigation · 1978 · 103 citations · Full text
W. R. Sheldon, C. ROWAN DEBOLD, William S. Evans et al. · The Journal of Clinical Endocrinology & Metabolism · 1985 · 89 citations